336 results
Page 3 of 17
6-K
EX-99.1
39gyk cmr0qgmghc2q
27 Feb 15
Live Filing
12:00am
6-K
EX-99.1
ss9 ds6k1
25 Feb 15
Live Filing
12:00am
6-K
EX-99.1
f7uv90sn35ixevsjtvm
24 Feb 15
TEVA ANNOUNCES POSITIVE RESULTS FOR TEV-48125 IN PHASE IIb CHRONIC MIGRAINE STUDY MEETING PRIMARY AND SECONDARY ENDPOINTS
12:00am
6-K
EX-99.1
bwhmcw9
23 Feb 15
Live Filing
12:00am
6-K
EX-99.1
bdh ynccm9kz
20 Feb 15
Teva to Present New Respiratory Data at 2015 Annual Meeting of the American Academy of Allergy, Asthma and Immunology
12:00am
6-K
EX-99.1
h8ts1
5 Feb 15
Live Filing
12:00am
6-K
EX-99.1
bsm0 dud6
5 Feb 15
Teva Reports Fourth Quarter and Full Year 2014 Results
12:00am
6-K
EX-99.1
89kygtpm5r8ny5v
26 Jan 15
Teva Receives Fda Approval for First Generic Nexium® Delayed-release Capsules In the United States
12:00am
6-K
EX-99.1
qrafj8ozb dxpg
20 Jan 15
Teva Announces U.S. Supreme Court Decision to Reverse Federal Circuit Court’s Judgment on COPAXONE®20 mg/mL Case and Remand for Further Review
12:00am
6-K
EX-99.1
qb9r4kk
7 Jan 15
Teva Launches Generic Diovan® In the United States
12:00am
6-K
EX-99.1
aaylbdx
23 Dec 14
Live Filing
12:00am
6-K
EX-99.1
kue7r72psu3he
19 Dec 14
First Waterless Nasal Allergy Spray Approved for Children as Young as Four Years of Age
12:00am
6-K
EX-99.1
ih2u4u
11 Dec 14
Teva Provides 2015 Business Outlook
12:00am
6-K
EX-99.1
h9ax hkhtu72h
11 Dec 14
Teva Announces Launch of First Generic Celebrex® Capsules In the United States
12:00am
6-K
EX-99.1
l0h9gja87avfc7 6qpn
4 Dec 14
Live Filing
12:00am
6-K
EX-99.1
k0qmz0ru ep3k26hyr
1 Dec 14
Live Filing
12:00am
6-K
EX-99.1
zdp1pl29gul25
1 Dec 14
Teva Announces Launch of Generic Exforge HCT® Tablets In the United States
12:00am
6-K
EX-99.1
6but7s yqa
26 Nov 14
Prof. Yitzhak Peterburg Elected Chairman of Teva’s Board of Directors
12:00am
6-K
EX-99.1
kw4drxghrlynt4rxq
18 Nov 14
Live Filing
12:00am